Treatment of non-small cell lung cancer and adenocarcinoma

Treating adenocarcinoma with bevacizumab

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Implementation of individualised treatment and the WINTHER trial

Importance of personalised medicine and the WIN Consortium

Achievements of the WIN Consortium

Goal of the 2013 WIN Symposium

Approaches to treatment of brain metastasis

Myc inhibition in pre-clinical mouse models

Immunotherapy in melanoma and other cancers